Genmab | GEN - Loan Capital

Stock Price
1,751.50
Daily Change
-7.00 -0.40%
Monthly
1.54%
Yearly
38.08%
Q2 Forecast
1,668.29

Genmab reported DKK5.14B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Almirall EUR 324.81M 61.32M Dec/2025
Amgen USD 50B 2.43B Dec/2025
argenx SE USD 35.57M 3.05M Jun/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Bayer EUR 31.83B 877M Dec/2025
BioMarin Pharmaceutical USD 597.18M 513K Dec/2025
Demant DKK 18.98B 3.71B Dec/2025
Fresenius Medical Care EUR 4.85B 4.49B Dec/2025
Galapagos EUR 5.19M 574K Dec/2025
Genmab DKK 5.14B 5.01B Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
GN Store Nord DKK 8.9B 9M Dec/2025
GRIFOLS EUR 8.47B 624.81M Dec/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Insmed USD 540.96M 1.24M Dec/2025
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.73B 277M Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 15.72B 2.45B Dec/2025
UCB EUR 2.18B 634M Dec/2025